Caricamento...
JAK Inhibitors and other Novel Agents in Myeloproliferative Neoplasms: Are We Hitting the Target?
The discovery of somatic mutations in the JAK-STAT signaling pathway was a major breakthrough in our understanding of the molecular pathogenesis of the myeloproliferative neoplasms (MPNs) polycythemia vera, essential thrombocytosis, and primary myelofibrosis. This finding led to the development of s...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573410/ https://ncbi.nlm.nih.gov/pubmed/23556090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620711410095 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|